{
  "id": 17302728,
  "title": "Why CareDx Stock Soared Today",
  "url": "https://urgent.news/2026/10/30/why-caredx-stock-soared-today",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-30T22:04:26.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/30/why-caredx-stock-soared-today/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "CareDx (CDNA) experienced a significant surge in its stock price on Friday after the medical diagnostics company reported robust growth figures. In the third quarter, the company's revenue increased by 39% year-over-year, reaching $139 million. This growth was primarily attributed to a 65% rise in testing services revenue, which hit $119 million. Additionally, testing volumes surged by 51% to 75,900, largely due to CareDx's acquisition of cancer blood-test maker Naveris in July.\n\nDuring a conference call with analysts, CareDx CEO John Hanna emphasized the demand for actionable precision molecular information by clinicians to inform patient treatment decisions. Moreover, the growth in CareDx's pharmacy services contributed to a 31% increase in patient and digital solutions revenue to $20 million. Consequently, the company's earnings before interest, taxes, depreciation, and amortization (EBITDA) doubled to $30 million.\n\nLooking ahead, CareDx anticipates full-year revenue growth of roughly 38% to $525 million in 2026. Management has also raised its adjusted EBITDA target to $90 million to $100 million, up from a previous forecast of $66 million to $78 million. The company is witnessing significant clinical interest in how molecular information can guide more decisions throughout a patient's care journey, while simultaneously making their solutions more accessible for providers and patients. CareDx believes these trends present meaningful opportunities for sustained profitable expansion.",
  "summary": "The precision medicine pioneer is helping to improve patient care.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Why CareDx Stock Soared Today",
        "url": "https://urgent.news/2026/10/30/why-caredx-stock-soared-today-17303988",
        "published": "2026-10-30T22:24:26.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}